Literature DB >> 23499625

Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation.

Tian-You Ling1, Xiao-Li Wang, Qiang Chai, Tin-Wah Lau, Celeste M Koestler, Soon J Park, Richard C Daly, Kevin L Greason, Jin Jen, Li-Qun Wu, Wei-Feng Shen, Win-Kuang Shen, Yong-Mei Cha, Hon-Chi Lee.   

Abstract

BACKGROUND: MicroRNAs are important regulators of gene expression, including those involving electrical remodeling in atrial fibrillation (AF). Recently, KCNN3, the gene that encodes the small-conductance calcium-activated potassium channel 3 (SK3), was found to be strongly associated with AF.
OBJECTIVES: To evaluate the changes in atrial myocardial microRNAs in patients with permanent AF and to determine the role of microRNA on the regulation of cardiac SK3 expression.
METHODS: Atrial tissue obtained during cardiac surgery from patients (4 sinus rhythm and 4 permanent AF) was analyzed by using microRNA arrays. Potential targets of microRNAs were predicted by using software programs. The effects of specific microRNAs on target gene expression were evaluated in HL-1 cells from a continuously proliferating mouse hyperplastic atrial cardiomyocyte cell line. Interactions between microRNAs and targets were further evaluated by using luciferase reporter assay and by using Argonaute pull-down assay.
RESULTS: Twenty-one microRNAs showed significant (>2-fold) changes in AF. MicroRNA 499 (miR-499) was upregulated by 2.33-fold (P < .01) in AF atria, whereas SK3 protein expression was downregulated by 46% (P < .05). Transfection of miR-499 mimic in HL-1 cells resulted in the downregulation of SK3 protein expression, while that of miR-499 inhibitor upregulated SK3 expression. Binding of miR-499 to the 3' untranslated region of KCNN3 was confirmed by luciferase reporter assay and by the increased presence of SK3 mRNA in Argonaute pulled-down microRNA-induced silencing complexes after transfection with miR-499.
CONCLUSION: Atrial miR-499 is significantly upregulated in AF, leading to SK3 downregulation and possibly contributing to the electrical remodeling in AF.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499625      PMCID: PMC3710704          DOI: 10.1016/j.hrthm.2013.03.005

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  31 in total

1.  MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation.

Authors:  Jing Zhou; Kuei-Chun Wang; Wei Wu; Shankar Subramaniam; John Y-J Shyy; Jeng-Jiann Chiu; Julie Y-S Li; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

2.  miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes.

Authors:  Harsh Dweep; Carsten Sticht; Priyanka Pandey; Norbert Gretz
Journal:  J Biomed Inform       Date:  2011-05-14       Impact factor: 6.317

3.  Ionic mechanisms of electrical remodeling in human atrial fibrillation.

Authors:  R F Bosch; X Zeng; J B Grammer; K Popovic; C Mewis; V Kühlkamp
Journal:  Cardiovasc Res       Date:  1999-10       Impact factor: 10.787

4.  Small-conductance calcium-activated potassium channel and recurrent ventricular fibrillation in failing rabbit ventricles.

Authors:  Su-Kiat Chua; Po-Cheng Chang; Mitsunori Maruyama; Isik Turker; Tetsuji Shinohara; Mark J Shen; Zhenhui Chen; Changyu Shen; Michael Rubart-von der Lohe; John C Lopshire; Masahiro Ogawa; James N Weiss; Shien-Fong Lin; Tomohiko Ai; Peng-Sheng Chen
Journal:  Circ Res       Date:  2011-02-24       Impact factor: 17.367

Review 5.  Molecular basis of electrical remodeling in atrial fibrillation.

Authors:  D R Van Wagoner; J M Nerbonne
Journal:  J Mol Cell Cardiol       Date:  2000-06       Impact factor: 5.000

6.  Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition.

Authors:  Jonas G Diness; Lasse Skibsbye; Thomas Jespersen; Emil D Bartels; Ulrik S Sørensen; Rie S Hansen; Morten Grunnet
Journal:  Hypertension       Date:  2011-04-18       Impact factor: 10.190

7.  Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.

Authors:  Scot J Matkovich; Yuanxin Hu; William H Eschenbacher; Lisa E Dorn; Gerald W Dorn
Journal:  Circ Res       Date:  2012-06-29       Impact factor: 17.367

8.  Screening of KCNN3 in patients with early-onset lone atrial fibrillation.

Authors:  Morten S Olesen; Javad Jabbari; Anders G Holst; Jonas B Nielsen; Daniel A Steinbrüchel; Thomas Jespersen; Stig Haunsø; Jesper H Svendsen
Journal:  Europace       Date:  2011-03-11       Impact factor: 5.214

9.  Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.

Authors:  Sophie Cardin; Eduard Guasch; Xiaobin Luo; Patrice Naud; Khaï Le Quang; YanFen Shi; Jean-Claude Tardif; Philippe Comtois; Stanley Nattel
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-08-26

10.  The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation.

Authors:  A J Workman; K A Kane; A C Rankin
Journal:  Cardiovasc Res       Date:  2001-11       Impact factor: 10.787

View more
  48 in total

Review 1.  Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China.

Authors:  Z W Pan; Y J Lu; B F Yang
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

Review 2.  Circulating miR-499 as a potential biomarker for acute myocardial infarction.

Authors:  Yunyi Xin; Chengjian Yang; Zhijun Han
Journal:  Ann Transl Med       Date:  2016-04

Review 3.  MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.

Authors:  Ying Huang; Jun Li
Journal:  J Physiol Biochem       Date:  2015-04-04       Impact factor: 4.158

Review 4.  MicroRNAs in cardiovascular ageing.

Authors:  Timon Seeger; Reinier A Boon
Journal:  J Physiol       Date:  2015-07-05       Impact factor: 5.182

5.  SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyR.

Authors:  Tae Yun Kim; Radmila Terentyeva; Karim H F Roder; Weiyan Li; Man Liu; Ian Greener; Shanna Hamilton; Iuliia Polina; Kevin R Murphy; Richard T Clements; Samuel C Dudley; Gideon Koren; Bum-Rak Choi; Dmitry Terentyev
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

6.  MicroRNA expression signatures of atrial fibrillation: The critical systematic review and bioinformatics analysis.

Authors:  Nan-Nan Shen; Chi Zhang; Zheng Li; Ling-Cong Kong; Xin-Hua Wang; Zhi-Chun Gu; Jia-Liang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-25

7.  F-box protein-32 down-regulates small-conductance calcium-activated potassium channel 2 in diabetic mouse atria.

Authors:  Tian-You Ling; Fu Yi; Tong Lu; Xiao-Li Wang; Xiaojing Sun; Monte S Willis; Li-Qun Wu; Win-Kuang Shen; John P Adelman; Hon-Chi Lee
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

8.  Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release.

Authors:  David Y Chiang; Natee Kongchan; David L Beavers; Katherina M Alsina; Niels Voigt; Joel R Neilson; Heinz Jakob; James F Martin; Dobromir Dobrev; Xander H T Wehrens; Na Li
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-11

Review 9.  Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Authors:  Delphine Fontaine; Sandy Figiel; Romain Félix; Sana Kouba; Gaëlle Fromont; Karine Mahéo; Marie Potier-Cartereau; Aurélie Chantôme; Christophe Vandier
Journal:  J Lipid Res       Date:  2020-04-07       Impact factor: 5.922

10.  Association of Small-Conductance Calcium-Activated Potassium Channels and Atrial Fibrillation - How Far Have We Gone?

Authors:  Shu-Hsuan Chang; Sheng-Nan Chang; Lian-Yu Lin; Ling-Ping Lai; Chuen-Den Tseng; Yi-Chih Wang; Chih-Chieh Yu; Fu-Tien Chiang; Juey-Jen Hwang; Jiunn-Lee Lin; Chia-Ti Tsai
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.